U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07578415) titled 'Shared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)' on May 05.
Brief Summary: Background and Purpose:
Deciding on the best treatment for HER2-negative metastatic breast cancer (MBC) is a complex process. Patients often have unique values and preferences regarding their care and quality of life. Shared Decision Making (SDM) is a communication process where doctors and patients work together to make healthcare choices. This study aims to evaluate whether providing specific SDM training to oncologists and educational materials to patients can improve the quality of these conversations and make the ...